Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.

Despite the lack of concrete evidence in the field, MIT researchers placed a bet that their framework would work.

By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.

The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.

Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to

Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to

Paper-based blood test developed by SMART researchers can rapidly determine the presence of SARS-CoV-2 neutralizing antibodies.

The technology could be developed as a rapid diagnostic for Covid-19 or other emerging pathogens.

The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.

Researchers have now created a simple, inexpensive diagnostic test that allows users to test themselves for multiple variants of the SARS-CoV-2 virus at home, using just a sample of their saliva.